Clinical Trials
2 trialsNCT01347866 2018-10-29
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Pfizer
Phase 1 Terminated
NCT00708773 2017-01-04
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
University of Chicago
Phase 1 Completed